Feeds
47589 items (47589 unread) in 74 feeds
Acinar Cell Carcinoma
(297 unread)
Acinic Cell Carcinoma
(223 unread)
Adenoid Cystic Carcinoma
(955 unread)
Adrenal Gland Cancer
(4201 unread)
Ampulla Of Vater
(1085 unread)
Anal Cancer
(4722 unread)
Angiosarcoma
(1447 unread)
Appendix Cancer
(643 unread)
Bile Duct Cancer
(5915 unread)
Brain and CNS
(6299 unread)
Carcinoid
(2041 unread)
Endocrine/Neuroendocrine
(5143 unread)
Gall Bladder Cancer
(2178 unread)
Hemangioendothelioma
(637 unread)
Hepatoblastoma
(687 unread)
Pancreas
(653 unread)
Phyllodes
(366 unread)
PMP and Mucinous Tumors
(430 unread)
Rhabdomyosarcoma
(1847 unread)
Sarcoma
(7820 unread)
Google - Angiosarcoma (100 unread)
-
Athenex, Inc. (ATNX) Reaches $10.58 After 8.00% Up Move; Oconee Federal Financial (OFED)'s Sentiment Is 0.41 - MЕSА Wееkly
Posted: October 22nd, 2019, 12:48pm GMT
-
23andMe Wants Everyone to Get Used to Sharing Their Genetic Data - VICE
Posted: October 21st, 2019, 3:40am GMT
-
Angiosarcomas Treatment Market Growth Analysis, Opportunities with top key playe - openPR
Posted: October 21st, 2019, 3:34am GMT
-
Comparison of TRACON Pharmaceuticals Inc. (TCON) and MeiraGTx Holdings plc (NASDAQ:MGTX) - MЕSА Wееkly
Posted: October 20th, 2019, 2:16am GMT
-
Altimmune Inc. (ALT) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Comparing side by side - MЕSА Wееkly
Posted: October 19th, 2019, 6:03pm GMT
-
23andMe Wants Everyone to Get Used to Sharing Their Genetic Data - Motherboard
Posted: October 18th, 2019, 8:21pm GMT
-
TRACON Pharmaceuticals (NASDAQ:TCON) Trading Up 7.5% - Slater Sentinel
Posted: October 18th, 2019, 11:53am GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Trading Up 7.5% Slater Sentinel -
TRACON Pharmaceuticals (NASDAQ:TCON) Trading Up 7.5% - Covington Journal
Posted: October 18th, 2019, 11:53am GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Trading Up 7.5% Covington Journal -
Cam Group Holding A Has Lowered Its Merck & Co (MRK) Position; Athenex (ATNX) Sellers Increased By 2.51% Their Shorts - MЕSА Wееkly
Posted: October 18th, 2019, 10:15am GMT
-
Reviewing Chiasma Inc. (CHMA)'s and TRACON Pharmaceuticals Inc. (NASDAQ:TCON)'s results - MЕSА Wееkly
Posted: October 18th, 2019, 2:53am GMT
-
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Hoth Therapeutics Inc. (NASDAQ:HOTH)'s results - MЕSА Wееkly
Posted: October 17th, 2019, 3:25am GMT
-
Contrasting of TRACON Pharmaceuticals Inc. (TCON) and Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP) - MЕSА Wееkly
Posted: October 17th, 2019, 11:10pm GMT
-
TRACON Pharmaceuticals (NASDAQ:TCON) Trading 7.5% Higher - Riverton Roll
Posted: October 17th, 2019, 10:37pm GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Trading 7.5% Higher Riverton Roll -
Midnight Cancer Scare - Curetoday.com
Posted: October 16th, 2019, 2:17pm GMT
Midnight Cancer Scare Curetoday.com -
Contrasting of TRACON Pharmaceuticals Inc. (TCON) and Kazia Therapeutics Limited (NASDAQ:KZIA) - MЕSА Wееkly
Posted: October 16th, 2019, 12:39pm GMT
-
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and iBio Inc. (NYSEAMERICAN:IBIO)'s results - MЕSА Wееkly
Posted: October 15th, 2019, 9:36pm GMT
-
Short Interest in TRACON Pharmaceuticals Inc (NASDAQ:TCON) Rises By 12.1% - TechNewsObserver
Posted: October 15th, 2019, 4:24pm GMT
-
‘Heartbeat’ of community stops - Albuquerque Journal
Posted: October 15th, 2019, 12:33pm GMT
‘Heartbeat’ of community stops Albuquerque Journal -
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and VistaGen Therapeutics Inc. (NASDAQ:VTGN)'s results - MЕSА Wееkly
Posted: October 15th, 2019, 12:29pm GMT
-
Angiosarcomas Treatment Market Report, History and Forecast 2019-2026 - Gazette Quest
Posted: October 15th, 2019, 11:49am GMT
-
HOOKIPA Pharma Inc. (HOOK) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Contrasting side by side - MЕSА Wееkly
Posted: October 15th, 2019, 8:14am GMT
-
Comparison of TRACON Pharmaceuticals Inc. (TCON) and Spectrum Pharmaceuticals Inc. (NASDAQ:SPPI) - MЕSА Wееkly
Posted: October 15th, 2019, 1:15am GMT
-
Hepion Pharmaceuticals Inc. (HEPA)'s Financial Results Comparing With TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - MЕSА Wееkly
Posted: October 14th, 2019, 3:46am GMT
-
TRACON Pharmaceuticals Inc. (TCON) and Kezar Life Sciences Inc. (NASDAQ:KZR) Comparing side by side - MЕSА Wееkly
Posted: October 14th, 2019, 2:22am GMT
-
Contrasting of Zealand Pharma A/S (ZEAL) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) - MЕSА Wееkly
Posted: October 13th, 2019, 5:54pm GMT
-
Contrasting of TRACON Pharmaceuticals Inc. (TCON) and Mustang Bio Inc. (NASDAQ:MBIO) - MЕSА Wееkly
Posted: October 13th, 2019, 5:24am GMT
-
TRACON Pharmaceuticals Inc. (TCON) and Geron Corporation (NASDAQ:GERN) Comparison side by side - MЕSА Wееkly
Posted: October 13th, 2019, 4:38am GMT
-
TRACON Pharmaceuticals Inc. (TCON) and Dynavax Technologies Corporation (NASDAQ:DVAX) Contrasting side by side - MЕSА Wееkly
Posted: October 13th, 2019, 10:58pm GMT
-
Comparing of TRACON Pharmaceuticals Inc. (TCON) and Viking Therapeutics Inc. (NASDAQ:VKTX) - MЕSА Wееkly
Posted: October 13th, 2019, 10:30pm GMT
-
Breast Cancer most preventable cancer in women - Sunday Observer
Posted: October 12th, 2019, 6:10pm GMT
Breast Cancer most preventable cancer in women Sunday Observer -
TRACON Pharmaceuticals Inc. (TCON) and Jounce Therapeutics Inc. (NASDAQ:JNCE) Comparing side by side - MЕSА Wееkly
Posted: October 12th, 2019, 3:51pm GMT
-
Orphan Drugs Market Size, Demands, Overview, Demands, Manufacturers, Applications & Forecast to 2025 - Market Research Scoop
Posted: October 12th, 2019, 3:27pm GMT
-
TRACON Pharmaceuticals Inc. (TCON) and NewLink Genetics Corporation (NASDAQ:NLNK) Contrasting side by side - MЕSА Wееkly
Posted: October 12th, 2019, 12:22pm GMT
-
TRACON Pharmaceuticals, Inc. (TCON) Reaches $0.37 Yearly Low; Mesabi Trust (MSB) Has 0.63 Sentiment - MЕSА Wееkly
Posted: October 10th, 2019, 1:50pm GMT
-
Soft Tissue Sarcoma Treatment Market Promising Growth Opportunities over 2017 – 2025 - Space Market Research
Posted: October 8th, 2019, 8:10pm GMT
Soft Tissue Sarcoma Treatment Market Promising Growth Opportunities over 2017 – 2025 Space Market Research -
TRACON Pharmaceuticals (NASDAQ:TCON) Stock Rating Upgraded by Zacks Investment Research - Riverton Roll
Posted: October 8th, 2019, 3:22pm GMT
-
FDA Approves Pexidartinib for Symptomatic Tenosynovial Giant Cell Tumors - Oncology Learning Network
Posted: October 8th, 2019, 1:30pm GMT
FDA Approves Pexidartinib for Symptomatic Tenosynovial Giant Cell Tumors Oncology Learning Network -
A brief guide to the various types of breast cancers - The Herald-News
Posted: October 8th, 2019, 8:30am GMT
A brief guide to the various types of breast cancers The Herald-News -
Medical Tourism Market Growth Owning to Innovations in Technology 2018-2026 - Gazette Quest
Posted: October 8th, 2019, 5:35am GMT
-
CAGR of 6.8% , ORPHAN DRUGS Market is anticipated to reach $169 billion by 2022 | AbbVie, Aegerion Pharmaceuticals, Bristol-Myers Squibb Company - Space Market Research
Posted: October 7th, 2019, 2:51am GMT
-
Local News: Breast Cancer Awareness Month observed in October (10/5/19) - Nevada Herald
Posted: October 5th, 2019, 5:00am GMT
-
Soft Tissue Sarcoma Treatment Market Analysis, Growth by Top Companies, Trends by Types and Application, Forecast to 2017 – 2025 - Herald Space
Posted: October 4th, 2019, 6:10pm GMT
-
What Is Breast Cancer in Men? | Print Only | phillytrib.com - The Philadelphia Tribune
Posted: October 2nd, 2019, 2:27pm GMT
What Is Breast Cancer in Men? | Print Only | phillytrib.com The Philadelphia Tribune -
Healthy Competition Among Players To Create A Positive Growth Environment In The Soft Tissue Sarcoma Treatment Market 2017 – 2025 - Zebvo
Posted: October 2nd, 2019, 2:40am GMT
-
Addition of TRC105 to Pazopanib Provides No Benefit in Advanced Angiosarcoma - Oncology Learning Network
Posted: October 1st, 2019, 4:15pm GMT
Addition of TRC105 to Pazopanib Provides No Benefit in Advanced Angiosarcoma Oncology Learning Network -
Liver Cancer: Symptoms, Causes, Treatments And Prevention - Talking Democrat
Posted: September 30th, 2019, 7:09pm GMT
Liver Cancer: Symptoms, Causes, Treatments And Prevention Talking Democrat -
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Expected to Post Earnings of -$0.18 Per Share - TechNewsObserver
Posted: September 30th, 2019, 12:10pm GMT
-
The ERs of New York - Philippine Star
Posted: September 28th, 2019, 2:00pm GMT
The ERs of New York Philippine Star -
Soft Tissue Sarcoma Treatment Market Projected to Gain Significant Value by 2017 – 2025 - Herald Space
Posted: September 26th, 2019, 9:14pm GMT
-
Angiosarcoma Market Size 2019 Continues to Grow, Secures Top Tier Speakers - Daily News Collectors
Posted: September 26th, 2019, 2:59am GMT
Angiosarcoma Market Size 2019 Continues to Grow, Secures Top Tier Speakers Daily News Collectors -
Hepstall - Clarke County Democrat
Posted: September 25th, 2019, 7:00pm GMT
Hepstall Clarke County Democrat -
Hanmi Pharma to Unveil Additional Data from Phase 3 Clinical Trial for 'Oraxol' - BusinessKorea
Posted: September 25th, 2019, 3:10am GMT
-
UT Health working to fight children's cancer with Hyundai Hope on Wheels grant - KENS5.com
Posted: September 24th, 2019, 5:23pm GMT
-
On the Double: Immunotherapy Combinations in Liver Cancer - Curetoday.com
Posted: September 24th, 2019, 11:07am GMT
-
Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets - MD Linx
Posted: September 24th, 2019, 9:15am GMT
-
Prognostic stratification of clinical and molecular epithelioid hemangioendothelioma subsets - MD Linx
Posted: September 24th, 2019, 9:15am GMT
-
Hanmi's US partner to unveil results of anticancer drug study - Korea Biomedical Review
Posted: September 24th, 2019, 6:00am GMT
Hanmi's US partner to unveil results of anticancer drug study Korea Biomedical Review -
UT Health working to fight children's cancer with Hyundai Hope on Wheels grant - KENS5.com
Posted: September 24th, 2019, 5:00am GMT
-
Soft Tissue Sarcoma Treatment Market to receive overwhelming hike in Revenues by 2017 – 2025 - NewsVarsity
Posted: September 24th, 2019, 4:48am GMT
Soft Tissue Sarcoma Treatment Market to receive overwhelming hike in Revenues by 2017 – 2025 NewsVarsitySarcoma are the type of cancer that develops from tissues such as nerves, muscles, fats, blood vessels and deep skin tissues. It occurs in the blood vessels, ...
-
Comparison of TRACON Pharmaceuticals Inc. (TCON) and Oncternal Therapeutics Inc. (NASDAQ:ONCT) - CryptoCoinsTribune
Posted: September 24th, 2019, 2:55am GMT
Comparison of TRACON Pharmaceuticals Inc. (TCON) and Oncternal Therapeutics Inc. (NASDAQ:ONCT) CryptoCoinsTribuneWe will be contrasting the differences between TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Oncternal Therapeutics Inc. (NASDAQ:ONCT) as far as ...
-
Protalix BioTherapeutics Inc. (PLX) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Comparison side by side - The EN Herald
Posted: September 23rd, 2019, 8:38pm GMT
Protalix BioTherapeutics Inc. (PLX) and TRACON Pharmaceuticals Inc. (NASDAQ:TCON) Comparison side by side The EN HeraldThis is therefore a contrasting of the risk, analyst recommendations, profitability, institutional ownership, dividends, earnings and valuation in Protalix.
-
Angiosarcomas Treatment Market Dynamics, Segments and Supply Demand 2019-2027 - QbnNews
Posted: September 23rd, 2019, 1:20pm GMT
Angiosarcomas Treatment Market Dynamics, Segments and Supply Demand 2019-2027 QbnNewsRare and clinically highly variable, Sarcoma is a type of cancer that originates from mesenchymal cells transformation. Sarcoma defines as the major tumors, ...
-
Angiosarcomas Treatment - QbnNews
Posted: September 23rd, 2019, 1:20pm GMT
Angiosarcomas Treatment QbnNews -
For many in Nigeria, cancer care remains out of reach - Devex
Posted: September 23rd, 2019, 10:00am GMT
-
Athenex to Highlight Oral Paclitaxel Clinical Programs Targeting Various Solid Tumors at the ESMO Congress - EIN News
Posted: September 23rd, 2019, 9:06am GMT
-
HC Wainwright Begins Coverage on TRACON Pharmaceuticals (NASDAQ:TCON) - TechNewsObserver
Posted: September 23rd, 2019, 11:03pm GMT
-
TRACON Pharmaceuticals Inc. (TCON) and Asterias Biotherapeutics Inc. (:) Contrasting side by side - CryptoCoinsTribune
Posted: September 22nd, 2019, 5:32pm GMT
TRACON Pharmaceuticals Inc. (TCON) and Asterias Biotherapeutics Inc. (:) Contrasting side by side CryptoCoinsTribuneBoth TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Asterias Biotherapeutics Inc. (:) are Biotechnology companies, competing one another. We will ...
-
Angiosarcomas Treatment Market – Latest Innovations, Drivers and Industry Key Events 2019– 2027 - Commerce Gazette
Posted: September 22nd, 2019, 1:47pm GMT
Angiosarcomas Treatment Market – Latest Innovations, Drivers and Industry Key Events 2019– 2027 Commerce GazetteRare and clinically highly variable, Sarcoma is a type of cancer that originates from mesenchymal cells transformation. Sarcoma defines as the major tumors, ...
-
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Expected to Announce Earnings of -$0.19 Per Share - TechNewsObserver
Posted: September 22nd, 2019, 2:48am GMT
TRACON Pharmaceuticals Inc (NASDAQ:TCON) Expected to Announce Earnings of -$0.19 Per Share TechNewsObserverWall Street brokerages expect TRACON Pharmaceuticals Inc (NASDAQ:TCON) to post earnings per share (EPS) of ($0.19) for the current fiscal quarter, ...
-
TRACON Pharmaceuticals (NASDAQ:TCON) Coverage Initiated at HC Wainwright - Mayfield Recorder
Posted: September 21st, 2019, 9:25pm GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Coverage Initiated at HC Wainwright Mayfield Recorder -
Obituary: Warren "Mac" McAlister - Lewiston Sun Journal
Posted: September 21st, 2019, 6:04am GMT
Obituary: Warren "Mac" McAlister Lewiston Sun Journal -
HC Wainwright Begins Coverage on TRACON Pharmaceuticals (NASDAQ:TCON) - Slater Sentinel
Posted: September 21st, 2019, 12:18am GMT
HC Wainwright Begins Coverage on TRACON Pharmaceuticals (NASDAQ:TCON) Slater SentinelHC Wainwright initiated coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON) in a report published on Thursday, August 29th, ...
-
Comparing of TRACON Pharmaceuticals Inc. (TCON) and BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) - The EN Herald
Posted: September 21st, 2019, 10:45pm GMT
Comparing of TRACON Pharmaceuticals Inc. (TCON) and BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) The EN HeraldTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and BiondVax Pharmaceuticals Ltd. (NASDAQ:BVXV) compete with each other in the Biotechnology sector.
-
Soft Tissue Sarcoma Treatment Market ls expected to drive growth through 2017-2025 made by top research firm - Chicago Format
Posted: September 20th, 2019, 5:18am GMT
Soft Tissue Sarcoma Treatment Market ls expected to drive growth through 2017-2025 made by top research firm Chicago FormatSarcoma are the type of cancer that develops from tissues such as nerves, muscles, fats, blood vessels and deep skin tissues. It occurs in the blood vessels, ...
-
Soft Tissue Sarcoma Treatment Market ls expected to drive growth through 2017-2025 made by top research firm - Chicago Format
Posted: September 20th, 2019, 5:18am GMT
Soft Tissue Sarcoma Treatment Market ls expected to drive growth through 2017-2025 made by top research firm Chicago FormatSarcoma are the type of cancer that develops from tissues such as nerves, muscles, fats, blood vessels and deep skin tissues. It occurs in the blood vessels, ...
-
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and NextCure Inc. (NASDAQ:NXTC)'s results - CryptoCoinsTribune
Posted: September 20th, 2019, 4:38am GMT
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and NextCure Inc. (NASDAQ:NXTC)'s results CryptoCoinsTribuneTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and NextCure Inc. (NASDAQ:NXTC) are two firms in the Biotechnology that compete against each other.
-
Is Tracon Pharmaceuticals Inc (NASDAQ:TCON)'s Fuel Running High? Reports Show Less Sellers - The Altcoin Mercury
Posted: September 19th, 2019, 7:52pm GMT
Is Tracon Pharmaceuticals Inc (NASDAQ:TCON)'s Fuel Running High? Reports Show Less Sellers The Altcoin MercuryThe stock of Tracon Pharmaceuticals Inc (NASDAQ:TCON) registered a decrease of 9.01% in short interest. TCON's total short interest was 694600 shares in.
-
Soft Tissue Sarcoma Treatment Market to Record an Exponential CAGR by 2025 - Market Forecast
Posted: September 19th, 2019, 2:48pm GMT
Soft Tissue Sarcoma Treatment Market to Record an Exponential CAGR by 2025 Market ForecastSarcoma are the type of cancer that develops from tissues such as nerves, muscles, fats, blood vessels and deep skin tissues. It occurs in the blood vessels, ...
-
Hepstall - Clarke County Democrat
Posted: September 19th, 2019, 5:00am GMT
Hepstall Clarke County Democrat -
TRACON Pharmaceuticals Inc. (TCON) and Gamida Cell Ltd. (NASDAQ:GMDA) Comparing side by side - The EN Herald
Posted: September 18th, 2019, 9:19pm GMT
TRACON Pharmaceuticals Inc. (TCON) and Gamida Cell Ltd. (NASDAQ:GMDA) Comparing side by side The EN HeraldTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Gamida Cell Ltd. (NASDAQ:GMDA) have been rivals in the Biotechnology for quite some time. Below is a ...
-
Angiosarcomas Treatment Market Growth with Worldwide Industry Analysis to 2015-2023 - Spaceflight News
Posted: September 18th, 2019, 4:41pm GMT
Angiosarcomas Treatment Market Growth with Worldwide Industry Analysis to 2015-2023 Spaceflight NewsRare and clinically highly variable, Sarcoma is a type of cancer that originates from mesenchymal cells transformation. Sarcoma defines as the major tumors, ...
-
TRACON Pharmaceuticals (NASDAQ:TCON) Upgraded at Zacks Investment Research - Mayfield Recorder
Posted: September 17th, 2019, 12:39pm GMT
-
Soft Tissue Sarcoma Market Size 2019, Global Industry Overview, Share, Growth, Competitive Landscape, Key Players, Regional Forecast to 2023 - Press Release - Digital Journal
Posted: September 16th, 2019, 8:50pm GMT
Soft Tissue Sarcoma Market Size 2019, Global Industry Overview, Share, Growth, Competitive Landscape, Key Players, Regional Forecast to 2023 - Press Release Digital JournalSoft Tissue Sarcoma Market Research Report – By Treatment (Targeted Therapy, Chemotherapy, Anti-Angiogenesis Drugs, Radiation Therapy), By Disease ...
-
'Very surreal': Fundraiser for Sasha's on Shaw shooting victims set for this weekend - KMOV.com
Posted: September 16th, 2019, 5:00am GMT
-
What's Tracon Pharmaceuticals Inc (NASDAQ:TCON) Upside After This Short Interest Decrease? - The MAK Daily
Posted: September 15th, 2019, 3:26pm GMT
What's Tracon Pharmaceuticals Inc (NASDAQ:TCON) Upside After This Short Interest Decrease? The MAK DailyThe stock of Tracon Pharmaceuticals Inc (NASDAQ:TCON) registered a decrease of 9.01% in short interest. TCON's total short interest was 694600 shares in.
-
TRACON Pharmaceuticals (NASDAQ:TCON) Earns Buy Rating from Analysts at HC Wainwright - TechNewsObserver
Posted: September 15th, 2019, 5:14am GMT
-
PARP Inhibitor Maintenance Therapy for Pancreatic Cancer With BRCA Mutation - Oncology Learning Network
Posted: September 14th, 2019, 3:28pm GMT
PARP Inhibitor Maintenance Therapy for Pancreatic Cancer With BRCA Mutation Oncology Learning Network -
TRACON Pharmaceuticals (NASDAQ:TCON) Research Coverage Started at HC Wainwright - Mayfield Recorder
Posted: September 14th, 2019, 6:46am GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Research Coverage Started at HC Wainwright Mayfield RecorderHC Wainwright assumed coverage on shares of TRACON Pharmaceuticals (NASDAQ:TCON) in a report released on Thursday, August 29th, ...
-
Targeted Therapy as Early Treatment for BRAF V600E-Mutated CRC - Oncology Learning Network
Posted: September 13th, 2019, 7:13pm GMT
Targeted Therapy as Early Treatment for BRAF V600E-Mutated CRC Oncology Learning Network -
Soft Tissue Sarcoma Treatment Market to Record an Exponential CAGR by 2025 - Herald Space
Posted: September 13th, 2019, 6:36pm GMT
Soft Tissue Sarcoma Treatment Market to Record an Exponential CAGR by 2025 Herald SpaceSarcoma are the type of cancer that develops from tissues such as nerves, muscles, fats, blood vessels and deep skin tissues. It occurs in the blood vessels, ...
-
TRACON Pharmaceuticals (NASDAQ:TCON) Cut to Sell at Zacks Investment Research - Mayfield Recorder
Posted: September 13th, 2019, 10:32am GMT
TRACON Pharmaceuticals (NASDAQ:TCON) Cut to Sell at Zacks Investment Research Mayfield RecorderZacks Investment Research lowered shares of TRACON Pharmaceuticals (NASDAQ:TCON) from a hold rating to a sell rating in a research report released on ...
-
Comparing of TRACON Pharmaceuticals Inc. (TCON) and XOMA Corporation (NASDAQ:XOMA) - Stocks Beat
Posted: September 13th, 2019, 8:48am GMT
Comparing of TRACON Pharmaceuticals Inc. (TCON) and XOMA Corporation (NASDAQ:XOMA) Stocks BeatBoth TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and XOMA Corporation (NASDAQ:XOMA) are Biotechnology companies, competing one another. We will ...
-
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Precision BioSciences Inc. (NASDAQ:DTIL)'s results - Stocks Beat
Posted: September 13th, 2019, 1:45am GMT
Reviewing TRACON Pharmaceuticals Inc. (TCON)'s and Precision BioSciences Inc. (NASDAQ:DTIL)'s results Stocks BeatBoth TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Precision BioSciences Inc. (NASDAQ:DTIL) compete on a level playing field in the Biotechnology ...
-
TRACON Pharmaceuticals Inc. (TCON) and Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) Contrasting side by side - The EN Herald
Posted: September 12th, 2019, 3:27am GMT
TRACON Pharmaceuticals Inc. (TCON) and Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM) Contrasting side by side The EN HeraldAs Biotechnology businesses, TRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Rhythm Pharmaceuticals Inc. (NASDAQ:RYTM), are affected by compare.
-
My Dad Was A 9/11 First Responder. Then A Giant Tumour Started Growing In His Chest. - HuffPost UK
Posted: September 11th, 2019, 1:43pm GMT
-
Tracon Pharmaceuticals Inc (NASDAQ:TCON)'s Stock Is Buy After Less Market Selling - The MAK Daily
Posted: September 11th, 2019, 1:16pm GMT
Tracon Pharmaceuticals Inc (NASDAQ:TCON)'s Stock Is Buy After Less Market Selling The MAK DailyThe stock of Tracon Pharmaceuticals Inc (NASDAQ:TCON) registered a decrease of 9.01% in short interest. TCON's total short interest was 694600 shares in.
-
TRACON Pharmaceuticals Inc. (TCON) and Kiniksa Pharmaceuticals Ltd. (NASDAQ:KNSA) Comparing side by side - Stocks Beat
Posted: September 10th, 2019, 3:47pm GMT
TRACON Pharmaceuticals Inc. (TCON) and Kiniksa Pharmaceuticals Ltd. (NASDAQ:KNSA) Comparing side by side Stocks BeatTRACON Pharmaceuticals Inc. (NASDAQ:TCON) and Kiniksa Pharmaceuticals Ltd. (NASDAQ:KNSA) compete with each other in the Biotechnology sector.
-
My Dad Was A 9/11 First Responder. Then A Giant Tumor Started Growing In His Chest. - HuffPost
Posted: September 10th, 2019, 3:12pm GMT
-
Brokerages Anticipate TRACON Pharmaceuticals Inc (NASDAQ:TCON) Will Announce Earnings of -$0.19 Per Share - Slater Sentinel
Posted: September 10th, 2019, 10:59pm GMT
Brokerages Anticipate TRACON Pharmaceuticals Inc (NASDAQ:TCON) Will Announce Earnings of -$0.19 Per Share Slater SentinelEquities analysts expect that TRACON Pharmaceuticals Inc (NASDAQ:TCON) will report earnings per share of ($0.19) for the current fiscal quarter, Zacks reports ...
-
Orphan Drugs Market Analysis by Industry Value, Market Size, Top Companies and Growth Forecast - ScoopJunction
Posted: September 9th, 2019, 4:36pm GMT
Orphan Drugs Market Analysis by Industry Value, Market Size, Top Companies and Growth Forecast ScoopJunctionThe study provides detail insights about the manufacturers of the industry, regional/country level market size outlook, perceived the tendency of market, ...